Filter by patients with: All

What is Nightmare PTSD Phase 3 Clinical Trial?

Category: Others

false

NCT02236390 Integrating Sleep, Nightmare and PTSD Treatments is a randomized single blinded efficacy study. Specific behavioral interventions are evaluated to measure frequency of nightmares and presence of PTSD symptoms.

See patients taking Nightmare PTSD Phase 3 Clinical Trial

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
  • Major
  • Moderate
  • Slight
  • None
  • Can't tell
See all 17 patients that have used Nightmare PTSD Phase 3 Clinical Trial

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 0
Mild 0
None 0

Commonly reported side effects and conditions associated with Nightmare PTSD Phase 3 Clinical Trial

Side effect Patients Percentage
Persistent worrying 1
Last updated:
There are no evaluations for Nightmare PTSD Phase 3 Clinical Trial.